Another important factor influencing TGR5-mediated effects is the alteration of gut microbiota induced by metabolic disorders, such as T2D, nonalcoholic fatty liver disease, and obesity. This evidence concerns the gene GPBAR1 and metabolic dysfunction-associated steatotic liver disease.